We assessed two outcomes: agreement to be contacted for future research, a prerequisite for PRO participation, using multivariable logistic regression
It's an investigational drug currently in Phase 3 clinical trials Eli Lilly's TRIUMPH Phase 3 program includes multiple trials for obesity, type 2 diabetes, NASH, and cardiovascular outcomes Expected timeline: FDA submission in 2026, potential approval in 20272028 Phase 2 results showed 24.2% weight loss at 48 weeks, the highest ever recorded for a GLP-1 class medication How to access now: Clinical trial enrollment (free), compounding pharmacies (with important legal caveats), or research peptides (grey market) When approved, retatrutide will be the first triple-agonist obesity medication (GLP-1 + GIP + glucagon) Is Retatrutide FDA Approved
In other situations, the denial may be because certain requirements havent been met yet
Common myths about GLP-1 injection timing Misinformation about injection timing circulates widely on social media and forums
Prioritise lean protein at every meal to help preserve muscle mass during weight loss
Both are once-weekly compounds
